http://www.nytimes.com/2002/06/13/health/13NASA.html
OSTON,
June 12 — Applying an antibiotic to the noses of some surgery patients can
sharply reduce their risk of developing a severe infection in the surgical
wound, a new study has found.
Doctors discovered years ago that if surgery patients harbored the bacterium Staphylococcus aureus in their nasal cavities, the risk of infection in the wound was up to nine times that of those who did not.
|
|
|
|
But in this week's issue of The New England Journal of Medicine, being published on Thursday, researchers report that applying the antibiotic mupirocin, to eliminate the bacteria from the noses of surgery patients could cut the risk of wound infection nearly in half.
The bacterium is normally found in the noses of 25 to 30 percent of patients in hospitals and usually causes little harm, but it can cause serious problems if it contaminates wounds, especially in patients whose immune systems have been weakened.
The ointment is sold under the brand name Bactroban Nasal by
ALL INFORMATION, DATA, AND
MATERIAL CONTAINED, PRESENTED, OR PROVIDED HERE IS FOR GENERAL INFORMATION
PURPOSES ONLY AND IS NOT TO BE CONSTRUED AS REFLECTING THE KNOWLEDGE OR OPINIONS
OF THE PUBLISHER, AND IS NOT TO BE CONSTRUED OR INTENDED AS PROVIDING MEDICAL OR
LEGAL ADVICE. THE DECISION WHETHER OR NOT TO VACCINATE IS AN IMPORTANT AND
COMPLEX ISSUE AND SHOULD BE MADE BY YOU, AND YOU ALONE, IN CONSULTATION WITH
YOUR HEALTH CARE PROVIDER.